Latest Commercialisation News

Skin Elements Limited has completed a $2.5 million placement to fund the commercial rollout of its ECO Nurture bio-stimulant, targeting sustainable kiwifruit orchard protection in New Zealand.

Metallium Limited has halted trading on the ASX pending a significant announcement about a partnership and funding deal with a US firm related to its critical-metals recovery technology.

Prairie Lithium has locked in a decade-long agreement to supply lithium-bearing crystallite to Hydro Lithium’s South Korean refinery, marking a strategic step in its commercial-scale production and market entry.

Jade Gas Holdings has verified exceptionally high methane purity exceeding 97% at its Red Lake gasfield, underpinning its commercial LNG ambitions and opening new chemical feedstock opportunities.

VRX Silica Limited has expanded its Arrowsmith North project’s offtake commitments by 550,000 tonnes annually and appointed Pareto Securities to manage debt financing, reinforcing its path to production.

Neometals has signed a non-binding Letter of Intent with BML Ventures to jointly develop the Ironclad Gold Deposit, aiming for early production through a funded open-cut mining operation with profit sharing.

Bayan Mining has locked in an exclusive worldwide licence for advanced rare earth processing technologies developed at Colorado School of Mines, promising higher recovery rates and lower costs for its Desert Star Project near Mountain Pass.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

Aurora Labs has secured its first $250,000 order for AU4 propulsion engines from Sovereign Propulsion Systems, marking a key step in its commercialisation strategy targeting unmanned aerial vehicles and defence markets.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

Immuron Limited reports topline results from a Uniformed Services University trial of a third-party ETEC product that missed its primary endpoint, reaffirming commitment to its established Travelan dosing ahead of FDA discussions.

Firebird Metals has achieved a significant technical milestone with its manganese iron phosphate precursor outperforming China industry benchmarks, setting the stage for commercial production at its Australian Demonstration Plant in 2026.